Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombopoietin Receptor Agonist”

Showing 20 of 0 results

Not applicableStudy completedNCT02298075
What this trial is testing

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885555
What this trial is testing

Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 41
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Study completedNCT01168921
What this trial is testing

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
CLLLeukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT04346654
What this trial is testing

Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT00110799
What this trial is testing

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis CThrombocytopenia
GlaxoSmithKline 75
Large-scale testing (Phase 3)Study completedNCT02201290
What this trial is testing

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Novartis Pharmaceuticals 9
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Testing effectiveness (Phase 2)Study completedNCT05772546
What this trial is testing

Avatrombopag vs. Placebo for CIT in GI Malignancies

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia
Hanny Al-Samkari, MD 49
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Early research (Phase 1)Looking for participantsNCT06880081
What this trial is testing

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00922883
What this trial is testing

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

Who this might be right for
Anemia, AplasticAnemia, HypoplasticThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 43
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Not applicableLooking for participantsNCT07612319
What this trial is testing

Romiplostim for Oral TPO-RA Resistant ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University 60
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Not applicableStudy completedNCT00643929
What this trial is testing

LENS - Long-term Eltrombopag Observational Study

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07019545
What this trial is testing

A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hellenic Society of Hematology 14
Testing effectiveness (Phase 2)Study completedNCT00908037
What this trial is testing

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 82
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation